FDA Approves Pembrolizumab in Metastatic TMB-H Solid Tumors

By Oct 22, 2026

Regulatory Approvals — FDA Approves Pembrolizumab in Metastatic TMB-H Solid Tumors CancerNetwork

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 22, 2026.

By

Regulatory Approvals

Recon: FDA approves GSK hepatitis B drug; EQT to buy molecular testing firm Qiagen for $10.8B

Oct 22, 2026

Regulatory Approvals

FDA Approves Berotralstat Oral Pellets for Adults, Adolescents With HAE

Oct 22, 2026

Regulatory Approvals

FDA Approves First Generic Hormone Therapy Patch

Oct 22, 2026

FDA Approves Pembrolizumab in Metastatic TMB-H Solid Tumors

By

Financial News For All

SpaceX and Tesla Are Already Joined at the Hip. What a Formal Merger Would Mean.

As Exits Continue, Weil Works on Merger Deal, Tells Partners to Carry On

California State University faculty union asks members for strike authorization

Novolex Evergreen strike in Cedar Rapids ends

FDA Approves Pembrolizumab in Metastatic TMB-H Solid Tumors

By

Related Post

Recon: FDA approves GSK hepatitis B drug; EQT to buy molecular testing firm Qiagen for $10.8B

FDA Approves Berotralstat Oral Pellets for Adults, Adolescents With HAE

FDA Approves First Generic Hormone Therapy Patch

Financial News For All

SpaceX and Tesla Are Already Joined at the Hip. What a Formal Merger Would Mean.

As Exits Continue, Weil Works on Merger Deal, Tells Partners to Carry On

California State University faculty union asks members for strike authorization

Novolex Evergreen strike in Cedar Rapids ends